Coronary artery perforation during percutaneous intervention: incidence and outcome
- PMID: 12381642
- PMCID: PMC1767399
- DOI: 10.1136/heart.88.5.495
Coronary artery perforation during percutaneous intervention: incidence and outcome
Abstract
Objective: To examine the clinical outcome of percutaneous coronary intervention where the procedure was complicated by vessel perforation.
Setting: Tertiary referral centre.
Methods: The procedural records of 6245 patients undergoing coronary intervention were reviewed. In 52 patients (0.8%) the procedure was complicated by vessel perforation, ranging from wire exit to free flow of contrast into the pericardial space. The majority of lesions treated were complex (37% type B, 59% type C) and 9 of 52 (17%) were chronic occlusions. Ten patients (19%) received abciximab. Four underwent rotational atherectomy (8%).
Results: In 28 of 52 patients (54%) the perforation was benign and managed conservatively without the development of haemodynamically significant sequelae. In 24 of 52 (46%) a significant pericardial effusion ensued requiring drainage. Of these 24 procedures 6 had involved the treatment of a chronic occlusion (25%). Eight of the 24 patients were referred for emergency bypass surgery (33%), 3 of whom died. Of the remaining 16 not referred for surgery, 3 died. Of the 10 procedures complicated by vessel perforation where abciximab had been administered, 9 (90%) led to pericardial tamponade. Latterly 2 vessel perforations were successfully treated by the deployment of a covered stent.
Conclusions: Coronary artery perforation with sequelae during intervention is rare--26 of 6245 (0.4%). This complication was seen in the treatment of chronic occlusions, which are therefore not risk-free procedures. The development of pericardial tamponade carries a high mortality. While prompt surgical intervention may be life saving, expertise in the use of covered stents may provide a valuable rescue option for this serious complication. Caution should be exercised where coronary perforation occurs and abciximab has been used.
Figures
References
-
- Gruberg L, Pinnow E, Flood R, et al. Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2000;86:680–2. - PubMed
-
- Von Sohsten R, Kopistansky C, Cohen M, et al. Cardiac tamponade in the new device era: evaluation of 6999 consecutive percutaneous coronary interventions. Am Heart J 2000;140:279–83. - PubMed
-
- Kimbris D, Iskandrian AS, Goel I, et al. Transluminal coronary angioplasty complicated by coronary artery perforation. Cathet Cardiovasc Diagn 1982;8:481–7. - PubMed
-
- Grollier G, Bories H, Commeau P, et al. Coronary artery perforation during coronary angioplasty. Clin Cardiol 1986;9:27–9. - PubMed
-
- Topaz O, Cowley MJ, Vetrovec GW. Coronary artery perforation during angioplasty; angiographic detection and demonstration of complete healing. Cathet Cardiovasc Diagn 1992;27:284–8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources